GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
4
Ucap Cloud Information Technology Co.,Ltd
688228
5
Yangtze Optical Electronic
688143
US Stock MarketDetailed Quotes
TELO Telomir Pharmaceuticals
- 5.030
- +0.280+5.89%
Close Jan 24 16:00 ET
- 5.030
- 0.0000.00%
Post 20:01 ET
148.94MMarket Cap-6.49P/E (TTM)
5.080High4.670Low70.79KVolume4.850Open4.750Pre Close346.47KTurnover0.41%Turnover RatioLossP/E (Static)29.61MShares20.72052wk High335.33P/B87.85MFloat Cap3.11052wk Low--Dividend TTM17.46MShs Float20.720Historical High--Div YieldTTM8.63%Amplitude3.110Historical Low4.894Avg Price1Lot Size
Telomir Pharmaceuticals News
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Bay Shore Trust
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Yanez Michelle
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jerman Michael Allen
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MacPherson Edward Clouston
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Yanez Michelle
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Whalen Matthew Pratt
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Del Giudice Matthew Paul
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Del Giudice Matthew Paul
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Whalen Matthew Pratt
Trending Stocks
Discussing
Big Tech’s earnings season kicks off: How will market react?
🎙️ Discussion: 1. Can Big Tech earnings lead all sectors higher again? 2. How will the tech giants be affected by the "Trump Factor"?
Moomoo News Global
Jan 16 23:21
What You Need to Know Ahead of Big Tech Earnings